Additional file 3 of A blinded, randomized and controlled multicenter clinical trial to assess the efficacy and safety of Leisguard® as an immunotherapeutic treatment for healthy Leishmania infantum-seropositive dogs
收藏数据链接：
官方服务：
资源简介：
Additional file 3: Table S2. Endpoint ELISA results of the dogs at days 0, 120, 240 and 360.
提供机构：
figshare创建时间：
2024-08-14
